Active, Not Recruiting
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
NCT04770896
- Conditions
- Unresectable Hepatocellular Carcinoma
- Locations
-
- Medizinische Universität Innsbruck Innsbruck, Austria
- Uniklinikum Salzburg, LKH Salzburg, Austria
- Universitätsklinikum St. Pölten Sankt Pölten, Austria
- Klinik Favoriten Vienna, Austria